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than for other forms of atrial arrhythmias. Only one of three 
patients remained free of symptoms during the follow-up 
period. Recent reports have advocated the feasibility of 
radiofrequency atheter ablation in curing this arrhythmia. 5 
In their recent review on inappropriate sinus tachycardia, 
Krahn and coworkers 6 stated that the therapy of this arrhyth- 
mia is empiric. Therefore we believe that considering the 
severity of symptoms and the failure of catheter ablation 
attempts, a decisive therapeutic approach in these patients, 
including cardiac surgery, is justified. 
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RECURRENT INFECTIVE ENDOCARDITIS ONE YEAR AFTER MITRAL REPAIR IN A WOMAN 
ADDICTED TO DRUGS 
Jean-Jacques Monsuez, MD, a Daniel Vittecoq, MD, a Christophe Acar, MD, b John Evans, MD, a and 
Serge Witchitz, MD, ° Villejuif and Paris, France 
The presence of a prosthetic heart valve is one of the 
major factors associated with a shortened overall survival 
in patients with infective mitral valve endocarditis. 1-2 
Accordingly, mitral valve repair, which is technically pos- 
sible in this setting, has increasingly been used, especially 
in those patients at risk of relapsing infective endocardi- 
tis)' 2 This approach, which was initially intended to limit 
the subsequent risk of reinfection associated with pros- 
thetic valves, also provides an opportunity to treat medi- 
cally the recurrent episodes of infective ndocarditis. This 
option may be of value in the management of infective 
endocarditis n persons addicted to drugs. 
A 29-year-old woman was admitted to the hospital for 
infective ndocarditis. Three months before admission she 
returned to her intravenous drug abuse, which she had 
discontinued 1 year previously after a first episode of 
Staphylococcus aureus mitral valve endocarditis. At this 
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time, the other cardiac valves were not involved and there 
were no embolic events. The patient was given a 6-week 
antibiotic regimen consisting of methicillin and gentami- 
cin with adequate determination of serum bactericidal 
titers. Both fever and inflammatory syndrome disap- 
peared. In view of the severe mitral regurgitation resulting 
from a 2 cm perforation, the patient subsequently under- 
went mitral valve reconstruction consisting of repair of the 
posterior leaflet associated with implantation of a pros- 
thetic annuloplasty ring (Duran No. 29). An echocardio- 
graphic examination confirmed that the anatomic result of 
the surgical procedure was good, with only mild residual 
mitral regurgitation. 
The patient otally recovered and remained symptom- 
free until she was admitted again 1 year later with fever 
(39 ° C), chills, sweats, multiple skin petechiae, tachycar- 
dia, and a mitral regurgitation murmur. No signs of heart 
failure were observed, and she did not have hepatospleno- 
megaly. An electrocardiogram and a chest roentgeno- 
gram showed no abnormalities. Laboratory examinations 
showed polynucleosis (15,000/ram3), anemia (10.2 gm/dl), 
and a sedimentation rate of 90 mm at 1 hour. A methi- 
cillin-susceptible Staphylococcus aureus was isolated from 
blood cultures. Transthoracic followed by transesophageal 
echocardiography showed large valvular vegetations at- 
tached to the posterior leaflet of the mitral valve, which 
prolapsed within the left atrial chamber during systole, 
and a central mitral regurgitant jet. No annular abscess 
was seen (Fig. 1). Computed tomographic (CT) scans 
showed a large asymptomatic brain abscess (Fig. 2) and a 
renal-cortical bscess. A multiple-drug antibiotic regimen 
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Fig. 1. Transesophageal echocardiogram. Large vegetations involving the anterior (A) and posterior (P) 
mitral leaflets. The prosthetic ring is also seen (arrows). 
consisting of intravenous oxacillin (2 gm every 4 hours) 
associated with gentamicin (1 mg/kg every 8 hours), 
pefloxacin (400 mg every 12 hours), and rifampin (INN: 
rifampicin) (300 mg every 8 hours) was started. Determi- 
nation of serum bactericidal titers showed adequate val- 
ues. Gentamicin was discontinued after 3 weeks. Fever 
and petechiae disappeared, as did the renal abscess on the 
CT scan. Repeated CT brain scans showed progressive 
decrease in size of the brain abscess over 6 months, during 
which oxacillin, pefloxacin, and rifampin were maintained. 
Echocardiographic follow-up showed mild to moderate 
mitral regurgitation, no impairment of left ventricular 
function parameters, and no left ventricular enlargement. 
The size of the mitral vegetations slightly decreased over 
time. Finally, the patient otally recovered. She discontin- 
ued her use of illicit drugs and resumed her occupational 
activities without need for further surgery. Three months 
after stopping antibiotics, the patient remains well, afe- 
brile, and free of all symptoms but has a persistent systolic 
murmur of mitral insufficiency. 
The risk of endocarditis developing after implantation 
of a prosthetic valve for native valve endocarditis varies 
from 10% to 15% at 5 years. 2'3 On the other hand, 
recurrent infective endocarditis, observed in only 0.2 
patient-years among 340 unselected patients, remains an 
uncommon complication of mitral valve repair, 4 even in 
patients in whom this surgical procedure is performed for 
infective endocarditis. Indeed, there was no recurrent 
infection among 44 patients who underwent mitral repair 
(associated with implantation of a prosthetic annuloplasty 
ring in 35 cases) in two recent studies, a' 2 Moreover, the 
prevalence of neurologic omplications of left-sided na- 
tive valve endocarditis, up to 67% when Staphylococcus 
aureus is isolated, and the increased risk of postoperative 
25 hemorrhagic strokes after valve replacement ' also argue 
Fig. 2. CT brain scan. Right parietal and temporal ab- 
scesses, with peripheral contrast enhancement (+). 
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for mitral repair in patients such as those addicted to 
drugs, who have an increased risk of infective endocardi- 
tis. The present report showed another advantage of 
mitral repair, because the absence of a prosthetic valve 
allowed successful medical therapy without subsequent 
need for surgery. We cannot be certain that the presence 
of a prosthetic ardiac valve in such a severe septico- 
pyohemic state would have resulted in a worsened out- 
come, but it very likely would have. 
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Commentary 
Dr. Monsuez and colleagues are to be commended for 
the successful management of a difficult clinical problem. 
However, several cautionary comments are in order. 
The experience with mitral valve repair in patients 
considered to be at risk for relapsing infective ndocarditis 
is limited. Although mitral valve repair is associated with 
a higher overall reinfection-free survival than mitral valve 
replacement, as recently reported by Muehrcke and col- 
leagues I in a series of 146 patients, the advantage of mitral 
valve repair over replacement was not conclusively dem- 
onstrated in the subset of patients with active (acute) 
endocarditis. The advantage of mitral valve repair in 
patients with relapsing endocarditis who are addicted to 
drugs has also not been demonstrated. Furthermore, as 
emphasized by Muehrcke and colleagues 1 and by others, 
comparisons ofpatients with infective ndocarditis having 
valve replacement or valve repair can be misleading, 
particularly in the subset with active endocarditis. Never- 
theless, mitral valve repair is a highly satisfactory tech- 
nique for the treatment of infective ndocarditis n appro- 
priately selected patients and should be performed 
whenever possible. 
For a patient with a third episode of staphylococcal 
endocarditis associated with large mobile valvular vegeta- 
tions, mitral regurgitation, petechiae, brain and renal 
cortical abscesses, and persistence of large vegetations 
after a course of antibiotic therapy, a strong case could be 
made for mitral valve replacement. Freedom from recur- 
rent infection 3 months after cessation of antibiotic ther- 
apy does not guarantee freedom from subsequent infec- 
tion. 
Until more information becomes available about the 
fate of patients who have had mitral valve repair for 
infective endocarditis and in whom reinfection develops 
(particularly with the complications described in this 
patient), I would urge caution in accepting the method of 
management described in this report as the treatment of 
choice. 
Nicholas Z Kouchoukos, MD 
St. Louis, Mo. 
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